` ALBIO (Biosynex SA) vs DAX Index Comparison - Alpha Spread

ALBIO
vs
DAX Index

Over the past 12 months, ALBIO has underperformed DAX Index, delivering a return of -61% compared to the DAX Index's 29% growth.

Stocks Performance
ALBIO vs DAX Index

Loading
ALBIO
DAX Index
Add Stock
www.alphaspread.com

Performance Gap
ALBIO vs DAX Index

Loading
ALBIO
DAX Index
Difference
www.alphaspread.com

Performance By Year
ALBIO vs DAX Index

Loading
ALBIO
DAX Index
Add Stock

Competitors Performance
Biosynex SA vs Peers

DAX Index
ALBIO
ABT
ISRG
BSX
SYK
Add Stock

Biosynex SA
Glance View

Market Cap
24.3m EUR
Industry
Health Care

Biosynex SA engages in the development, production, and distribution of Rapid Diagnostics Tests (RDTs) for pathologies. The company is headquartered in Illkirch-Graffenstaden, Grand Est. The company went IPO on 2011-03-21. The Company’s products are used by biological and analytical services laboratories, obstetric units and emergency units, as well as in medical resource-limited settings. Biosynex SA specializes in four fields: tropical diseases, emergency markers, infectious diseases and autoimmunity. The Company’s products include Amnioquick (Obstetrics); Immunoquick Malaria Falciparum and Immunoquick Malaria +4 (Parasitology); Immunoquick Elifa HSV IGG, Immunoquick Elifa EBV G and Immunoquick Mono (Virology); Immunoquick Filtration CELIAC IgA and Immunoquick TG (Autoimmunology); and Immunoquick Tetanus (Bacteriology). The company operates through Fumouze Diagnostics and SR2B.

ALBIO Intrinsic Value
8.579 EUR
Undervaluation 85%
Intrinsic Value
Price
Back to Top